Company
United StatesPublic company, NYSE: BLCOBausch & Lomb, Inc. (NYSE: BLCO), Manchester, MO – FDA Inspections
Inspection records and compliance data for Bausch & Lomb, Inc. in Manchester, Missouri. 5 FDA inspections on record, 1 Form 483, last inspected November 22, 2024. Publicly traded as NYSE: BLCO.
Company Profile
This profile covers Bausch & Lomb, Inc. based in Manchester, Missouri, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 0
- NAI
- 4
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected January 19, 2012. Last inspected November 22, 2024.
Most cited issue areas
- Lack of or inadequate final acceptance procedures1 inspection
- Lack of or inadequate procedures1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 22, 2024 | Not classified | Medical Devices & Rad Health · Compliance: Medical Devices | 1251448 |
| October 10, 2019 | NAI | Medical Devices & Rad Health · Radiation Control and Health Safety Act | 1107243 |
| June 9, 2016 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 973794 |
| April 28, 2014 | NAI | Medical Devices & Rad Health · Compliance: Devices | 876296 |
| January 19, 2012 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 766406 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bausch & Lomb, Inc.
Stock ticker
BLCO
Exchange
NYSE
Share price
$19.96
Market cap
$7.1B
Price as of
November 6, 2026
FEI Number
1000119305
Address
499 Sovereign Ct, Manchester, Missouri 63011, United States
Country
United States
ID: eb33b19b-e9d4-4f4b-960b-e770091990d3